Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 25, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Announces Upcoming Presentations in June Investor Conferences

SHANGHAI and SAN FRANCISCO, May 25, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that...
May 24, 2021 09:21 ET | Source: Zai Lab Limited

Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer

SHANGHAI and SAN FRANCISCO, May 24, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced treatment of the...
May 10, 2021 07:32 ET | Source: Zai Lab Limited

Zai Lab Announces First Quarter 2021 Financial Results

SHANGHAI and SAN FRANCISCO, May 10, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced financial results...
April 26, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021

SHANGHAI and SAN FRANCISCO, April 26, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will...
April 23, 2021 10:49 ET | Source: Zai Lab Limited

Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option

SHANGHAI and SAN FRANCISCO, April 23, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company, today...
April 20, 2021 19:40 ET | Source: Zai Lab Limited

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

SHANGHAI and SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company, today...
April 19, 2021 16:05 ET | Source: Zai Lab Limited

Zai Lab Announces Proposed Public Offering of American Depositary Shares

SHANGHAI and SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company, today...
April 13, 2021 07:37 ET | Source: Zai Lab Limited

Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

Pre-specified interim analysis concluded with favorable recommendation to continue the LUNAR trial DMC stated accrual to 534 patients is likely unnecessary and possibly unethical for patients...
March 31, 2021 04:57 ET | Source: Zai Lab Limited

China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

China NMPA approval follows 2020 U.S. FDA approval for the treatment of patients with fourth-line GIST QINLOCK demonstrated a significant improvement in progression-free survival and a clinically...
March 01, 2021 07:00 ET | Source: Zai Lab Limited

Zai Lab Announces Financial Results for Second-half and Full-year 2020

-- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative...